AKT1 and prostate cancer: In addition, these findings provide insight into how the activated PI3-K/Akt pathway leads to elevated Skp2 expression and subsequent enhanced p27 destruction in human cancers, providing further evidence that elevated Akt activity and cytoplasmic Skp2 expression may be causative for breast and prostate cancer progression.